We are live on ! Find out more

VanEck Pharmaceutical ETF

PPH

Market cap $1.01B

109.44 USD

-0.16

0.15%

At close Updated Sep 11, 4:00 PM EDT

1 day

-0.15%

5 days

-4.54%

1 month

-2.3%

3 months

2.09%

6 months

3.21%

Year to date

5.51%

1 year

21.44%

5 years

47.75%

10 years

85.12%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 33.3%

Neutral 66.7%

Negative 0%

The Motley Fool

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.

The Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to 26 for the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF currently offers a significantly higher dividend yield and a lower expense ratio than its counterpart.

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.

Zacks Investment Research

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Zacks Investment Research

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

The Motley Fool

PPH vs. IYH: Which Healthcare Fund Is the Better Buy?

The iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broad exposure across the healthcare sector, whereas the VanEck Pharmaceutical ETF (NYSEMKT:PPH) concentrates specifically on pharmaceutical stocks. PPH offers a slightly lower expense ratio and a higher dividend yield than IYH.

PPH vs. IYH: Which Healthcare Fund Is the Better Buy?

The Motley Fool

VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?

VanEck Pharmaceutical ETF features a lower expense ratio of 0.36% compared to 0.58% for Invesco Biotechnology & Genome ETF. Invesco Biotechnology & Genome ETF delivered a higher 1-year total return of 47.3% but experienced a significantly deeper maximum drawdown of 34.7%.

VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?

Zacks Investment Research

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Launched on December 20, 2011, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

The Motley Fool

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

The State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio and higher assets under management than the VanEck Pharmaceutical ETF VanEck Pharmaceutical ETF focuses exclusively on pharmaceuticals while State Street Health Care Select Sector SPDR ETF covers medical equipment and healthcare services Historical data shows VanEck Pharmaceutical ETF has delivered higher 5-year growth but also experienced a deeper maximum drawdown

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

The Motley Fool

Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ

The iShares Global Healthcare ETF provides broader exposure with 110 holdings across various sub-sectors compared to the 26 positions in the VanEck Pharmaceutical ETF The VanEck Pharmaceutical ETF features a lower expense ratio of 0.36% and a higher trailing dividend yield of 2.00% While the iShares Global Healthcare ETF has experienced lower historical drawdowns, the VanEck Pharmaceutical ETF has delivered higher total returns over the last five years

Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ

The Motley Fool

For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?

iShares Global Healthcare ETF offers broader exposure with 110 holdings across the global healthcare sector, while VanEck Pharmaceutical ETF concentrates on 26 pharmaceutical-specific companies VanEck Pharmaceutical ETF has delivered higher total returns over the last year and five years alongside a higher dividend yield of 2.0% iShares Global Healthcare ETF manages significantly more assets at $4.1 billion but carries a slightly higher expense ratio of 0.4% compared to 0.36% for the VanEck fund

For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?

AI Bubble Risks Make Dividend Stocks Attractive Again

I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics, and inflation while generating attractive income. My "ALLKA Dividend Rating" model separates quality dividend opportunities from yield traps by analyzing dividend sustainability, growth prospects, and valuation. The article explores three dividend strategies, "High-Yield Defensive," "Balanced Income," and "Pure Growth," designed for goals ranging from high yield to dividend growth.

AI Bubble Risks Make Dividend Stocks Attractive Again

See News Rankings

Price charts implemented using Lightweight Charts™